Clinical Trial Application (IND) for BioRay Pharmaceutical’s BR105 Injection Receives U.S. FDA Approval
BioRay Pharmaceutical Co., Ltd. (hereinafter referred to as “BioRay”) announced on October 7th that its clinical trial application for BR105 Injection has…